Inhibition of angiogenesis by extracellular protein kinase A

被引：10
|
作者：
Szkudlarek, Maria [1 ]
Bosio, Rual M. [2 ]
Wu, Qiong [1 ]
Chin, Khew-Voon [1 ,3 ,4 ]
机构：
[1] Univ Toledo, Dept Med, Coll Med, Toledo, OH 43614 USA
[2] Univ Toledo, Dept Surg, Coll Med, Toledo, OH 43614 USA
[3] Univ Toledo, Dept Biochem & Canc Biol, Coll Med, Toledo, OH 43614 USA
[4] Univ Toledo, Ctr Diabet & Endocrine Res, Coll Med, Toledo, OH 43614 USA
来源：
CANCER LETTERS | 2009年 / 283卷 / 01期
关键词：
ECPKA; Angiogenesis; Extracellular; PKA; Chorioallantoic; CANCER BIOMARKER; CYCLIC-AMP; CAMP; LOCALIZATION; EXPRESSION;
D O I：
10.1016/j.canlet.2009.03.027
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The cyclic-AMP dependent protein kinase (PKA) signaling pathway regulates cell growth, development, metabolism, and gene expression. Peripheral blood of cancer patients but not normal individuals, shows increased catalytic subunit levels of PKA (PKAc). We showed here that this extracellular form of PKAc (ECPKA) from conditioned media of cultured cancer cells as well as purified PKAc inhibit angiogenesis, using the in utero chicken embryo chorioallantoic membrane assay. Inhibition of angiogenesis is partially reversed by PKI, a peptide inhibitor of PKA, thus suggesting an anti-angiogenic role for ECPKA. The significance of ECPKA in cancer is discussed. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：68 / 73
页数：6
相关论文
共 50 条
  • [1] Regulation of angiogenesis by the extracellular matrix and protein kinase A
    Varner, J
    PROCEEDINGS OF THE 2ND INTERNATIONAL CONFERENCE ON TUMOR MICROENVIRONMENT PROGRESSION, THERAPY & PREVENTION, 2002, : 49 - 53
  • [2] Inhibition of endothelial cell survival and angiogenesis by protein kinase A
    Kim, S
    Bakre, M
    Yin, H
    Varner, JA
    JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (07): : 933 - 941
  • [3] Inhibition of protein kinase Cα activity inhibits angiogenesis
    Murakami, M
    Horowitz, A
    Simons, M
    CIRCULATION, 1999, 100 (18) : 404 - 404
  • [4] INHIBITION OF ANGIOGENESIS BY STAUROSPORINE, A POTENT PROTEIN-KINASE INHIBITOR
    OIKAWA, T
    SHIMAMURA, M
    ASHINO, H
    NAKAMURA, O
    KANAYASU, T
    MORITA, I
    MUROTA, S
    JOURNAL OF ANTIBIOTICS, 1992, 45 (07): : 1155 - 1160
  • [5] Inhibition of angiogenesis by a novel, selective inhibitor of protein kinase C-β.
    Derian, CK
    Zhang, HC
    Andrade-Gordon, P
    Maryanoff, BE
    Tuman, RW
    Addo, MF
    Croll, DR
    Damiano, BP
    Eckardt, AJ
    Emanuel, S
    Hecker, LR
    Johnson, DL
    McComsey, DF
    Skrzat, S
    Tominovich, R
    White, KB
    Ye, H
    BLOOD, 2003, 102 (11) : 534A - 534A
  • [6] Inhibition of protein-protein interactions in the extracellular signal-regulated kinase (ERK)
    Macias, AT
    Hancock, CN
    Lee, EK
    Yu, SY
    MacKerell, AD
    Shapiro, P
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U1337 - U1338
  • [7] INHIBITION OF ANGIOGENESIS BY ERBSTATIN, AN INHIBITOR OF TYROSINE KINASE
    OIKAWA, T
    ASHINO, H
    SHIMAMURA, M
    HASEGAWA, M
    MORITA, I
    MUROTA, S
    ISHIZUKA, M
    TAKEUCHI, T
    JOURNAL OF ANTIBIOTICS, 1993, 46 (05): : 785 - 790
  • [8] Inhibition of angiogenesis by a mouse sprouty protein
    Lee, SH
    Schloss, DJ
    Jarvis, L
    Krasnow, MA
    Swain, JL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (06) : 4128 - 4133
  • [9] Protein Kinase D in Vascular Biology and Angiogenesis
    Evans, Ian M.
    Zachary, Ian C.
    IUBMB LIFE, 2011, 63 (04) : 258 - 263
  • [10] Protein Kinase CK2 and Angiogenesis
    Montenarh, Mathias
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2014, 23 (02): : 153 - 158
12345